InvestorsHub Logo
Followers 81
Posts 1964
Boards Moderated 0
Alias Born 11/12/2003

Re: leifsmith post# 23425

Friday, 08/14/2015 3:58:33 PM

Friday, August 14, 2015 3:58:33 PM

Post# of 30990
Looks like they will also be presenting at the BioPharm America Conference in Boston the following week (Sept 15-17).

http://www.ebdgroup.com/bpa/presenters/prs_comps.php

If they can survive long enough to get to phase 2, we could see the same rocket launch as AQXP (earlier this week). I think most of us on this board know the potential based on how well anatabine citrate works for inflammation and how well it is tolerated.

http://www.benzinga.com/analyst-ratings/analyst-color/15/08/5751697/1-800-in-two-days-the-saga-of-aquinox-pharmaceuticals

excerpts...

Shares of Aquinox Pharmaceuticals Inc
AQXP 9.27% skyrocketed more than 350 percent Monday morning, hitting a 52-week high of $55.75.

The stock was trading at less than $2 per share last Thursday -- that's not a typo. Midway through Monday's trading, the stock is near the $38 mark.

JMHO,

NJ


Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.